Newsletter Subject

Endocarditis in patients with cocaine or opioid use disorder saw marked increase between 2011 to 2022

From

nih.gov

Email Address

NIDA@updates.nida.nih.gov

Sent On

Tue, Dec 13, 2022 03:30 PM

Email Preheader Text

Steep, recent increase indicates COVID-19 associated with higher risk of endocarditis, NIH-supported

Steep, recent increase indicates COVID-19 associated with higher risk of endocarditis, NIH-supported study finds [] [View as webpage / Share]( [NIH National Institute on Drug Abuse] NEWS [Close-up of a man looking out of a window.]( Endocarditis in patients with cocaine or opioid use disorder saw marked increase between 2011 to 2022 The incidence rate of [infective endocarditis]( – a rare but often fatal inflammation of the heart valves – among patients with cocaine use disorder or opioid use disorder increased from 2011 to 2022, with the steepest increase occurring from 2021 to 2022, a new study reports. Study findings contribute to expanding evidence of endocarditis as a significant and growing health concern for people who inject drugs, and further demonstrate that this risk has been exacerbated during the COVID-19 pandemic. [View Press Release]( Stay Connected [facebook]([twitter]([linkedin]([youtube]( --------------------------------------------------------------- View topics of interest, update your subscriptions, modify your password or email address, alter frequency of bulletins, or stop subscriptions at any time on your [Subscriber Preferences Page](. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit [subscriberhelp.govdelivery.com](. This service is provided to you at no charge by [National Institute on Drug Abuse](. --------------------------------------------------------------- This email was sent to {EMAIL} using govDelivery Communications Cloud on behalf of: National Institute on Drug Abuse · 3WFN MSC 6024 · 16071 Industrial Dr · Gaithersburg, MD 20877 [GovDelivery logo](

Marketing emails from nih.gov

View More
Sent On

02/10/2024

Sent On

25/09/2024

Sent On

24/09/2024

Sent On

03/09/2024

Sent On

29/08/2024

Sent On

15/08/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.